Treatment Action Group

An Activist’s Guide to Rifapentine TB Preventive Treatment: 3HP and 1HP

The new 2024 update of An Activist’s Guide to Rifapentine TB Preventive Treatment: 3HP and 1HP lays out what TB community advocates need to know about rifapentine-based TB preventive treatment.

Read More →

TAG webinar: TB diagnostics pipeline: New tools & opportunities to improve access to testing

On 15 May 2024, Treatment Action Group (TAG) will host a webinar on TB diagnostics pipeline: New tools & opportunities to improve access to testing.

Read More →

Mid-campaign report highlights what’s needed to win better, shorter TB treatments for all by end of 2024

With less than a year to go until the 1/4/6x24 Campaign deadline, the Getting Better Faster: Delivering on the Promise of New TB Treatments report outlines both progress made and remaining gaps toward achieving 1/4/6x24.

Read More →

CROI 2024 TB research round up

Treatment Action Group (TAG) released an overview of TB research data reported at the 31st Conference on Retroviruses and Opportunistic Infections (CROI 2024) held on 3-6 March 2024 in Denver, Colorado, USA.

Read More →

TAG's 2023 Pipeline Report: TB Treatment

Treatment Action Group launches the 2023 Tuberculosis Treatment Pipeline Report.

Read More →

TB preventive treatment community materials

Educational materials designed for community-based and civil society organizations to use to advocate for and teach people about TB preventive treatment.

Read More →

Statement from TAG, Global TB CAB on H56:IC31 Phase IIb trial results

The Global TB CAB and TAG commend the investigators for sharing results early and openly with a diverse group of key stakeholders, and urge the scientific community and funders to continue efforts to find different options to prevent TB.

Read More →

Report: TB Research Funding Trends 2005-2022

TB research and development funding perilously off track of UN commitments to end TB by 2030.

Read More →

TAG's 2023 Pipeline Report: TB Diagnostics

Treatment Action Group launches the 2023 Tuberculosis Diagnostics Pipeline Report.

Read More →

An Activist’s Guide to Shorter Treatment for Drug-Resistant TB

This new resource lays out what activists need to know about the new drug-resistant TB treatment regimens, and equips them with actions they can take and arguments they can use to advocate for access to those regimens.

Read More →

Page 1 of 23 · Total posts: 10

1 2 Last→